On 9 October 2026, KINWONG (03228.HK) announced that it expects revenue for the three months ended 30 September 2026 to range from approximately RMB 6.12 billion to RMB 6.98 billion, compared with revenue of RMB 3.987 billion in the same period last year.
On 11 October 2026, ST HLDGS (08305.HK) said it signed a procurement pact on 28 September with Letian Investment Holding (Guangdong) Group, which intends to buy the Group's goat milk products for five years at an annual minimum of about RMB 100 million.
On 9 October 2026, CORNERSTONE TEC (08391.HK) said vice chairman and executive Director Li Minqiang has taken a leave of absence with immediate effect for personal reasons, and will not perform any executive duties during the period.
On 12 October 2026, TRANSCENTA-B (06628.HK) said an "Anti-CLDN18.2 Antibodies and Diagnostic Uses Thereof" patent filed by its unit Suzhou Transcenta was granted by CNIPA, publication number CN115836090B, dated 25 September 2026.
On 12 October 2026, WASION HOLDINGS (03393.HK) said AMI meters of its unit Wasion Americas Inc. passed ANSI certification in the U.S., a key breakthrough in its North American power market expansion.
On 12 October 2026, WASION HOLDINGS (03393.HK) said it secured several smart grid orders in emerging Middle East markets with a total contract value of about RMB 1.25 billion (about HKD 1.47 billion), to be delivered over three years.
On 12 October 2026, PINE TECH (01079.HK) published a rights issue prospectus on a one-for-two basis at HKD 0.15 per rights share, issuing up to 713,350,869 rights shares to raise up to about HKD 107.0 million, non-underwritten.
On 12 October 2026, FWD (01828.HK) said its unit FWD Limited agreed on 10 October to buy a 25% stake in Bolttech Insurance (HK) for a base consideration of USD 20,720,000, a connected transaction subject to reporting and announcement.
On 12 October 2026, SEYOND (02665.HK) said its total LiDAR shipments in Q3 2026 were about 268,900 units, up 217% year on year, with the Robin series at about 200,900 units, up about 530%.
On 12 October 2026, LEADS BIOLABS-B (09887.HK) said vilasumu, a PD-L1/4-1BB bispecific antibody, received FDA Fast Track designation for first-line advanced biliary tract cancer, granted in nine days.
On 11 October 2026, PRODUCTIVE TECH (00650.HK) said it had won 29 new equipment orders since 24 March 2026, including 14 semiconductor equipment orders for single-wafer cleaning and furnace LPCVD, with revenue not yet recognised.
On 11 October 2026, HAICHANG HLDG (02255.HK) said controlling shareholder Yu Faxiang was placed under CSRC investigation on 9 October over suspected personal information disclosure violations, and the probe is unrelated to the Group.
On 11 October 2026, EDDING GENOR (06998.HK) said the Phase II IND for GB268, a PD-1/CTLA-4/VEGF trispecific antibody, with chemotherapy for first-line locally advanced or metastatic colorectal adenocarcinoma was approved by China's NMPA on 9 October.
On 11 October 2026, HANSOH PHARMA (03692.HK) said it refiled an EU marketing application for almonertinib (Aumseqa®) with the EMA on 29 September, and the EMA confirmed acceptance on 7 October, starting centralised review.
On 11 October 2026, LDROBOT (01236.HK) said it signed a pact with Huazhong University of Science and Technology on flexible 3D tactile sensing for embodied robots, covering sensor components and array systems with validation on dexterous hands and robotic arms.
Hong Kong recent listings diverged this week, with BAIGE DIGITAL up 27.36%; CHINA SANDI down 45.83%; Z.AI led turnover at HK$2.089 billion; REFIRE slid 96.89%.
